Biotech company Noxilizer, based out of the University of Maryland BioPark, has set up a sales operation in Europe.
The company, which “manufactures sterilization technology for medical devices and equipment,” announced in a press release that its expansion to Europe “is intended to accelerate the global acceptance of nitrogen dioxide sterilization as a powerful, efficient, and cost-saving alternative to traditional sterilization methods.”
Read more at Noxilizer.
Companies:
University of Maryland BioPark
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
The case for storytelling: Want your region’s tech scene to grow? Start with a story, new data says
The fall of giants: How technical leadership gaps broke three once-mighty tech companies
Hey Baltimore: How well do you know local tech news?
